Top Markets
#1 Prom Prom +32.17%
#2 QuantixAI QuantixAI +31.15%
#3 Velvet Velvet +29.00%
#4 MowCat MowCat +28.71%
#5 Tutorial Tutorial +25.72%
#6 UnifAI Network UnifAI Network +23.74%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +21.78%
#8 MarsCoin MarsCoin +18.77%
#9 Versatize Coin Versatize Coin +16.65%
#10 Kinesis Silver Kinesis Silver +14.47%
Coin of the day
Prom Prom
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Rang in Aktien #20720
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Aktienkurs
$22.35
Marktkapitalisierung
$123.66M
Veränderung (1 Tag)
-0.75%
Veränderung (1 Jahr)
-22.53%
Land
PL
Handel Bioceltix S.a. (BCX)

Kategorie

Healthcare
Kursverlauf für Bioceltix S.a. (BCX)
Höchster Schlusskurs: $22.78 am 2026-08-01

Niedrigster Schlusskurs: $8.58 am 2021-11-01
Kursverlauf der Aktie von Bioceltix S.a. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 5.94%
2025 17.75%
2024 -9.56%
2023 146.80%
2022 -15.69%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.27 -15.19%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $766.29 8.42%
CH